Statistics
Publications
28
Citations
2.5K
H-Index
20
Active since
1983
Christopher Carlson is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and life sciences.
Publications per year
1983–2018
28
28
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text
Medicine, Neurology, Pharmacology +17
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 365 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
1–5 of 28